Lab Says T; POCT Says I Does it really matter?

24/11/2026

Webinar

Join Abbott for the webinar

Lab Says T; POCT Says I

Does it really matter?

24 Nov. 2026
12:00 – 1:00 PM GMT

Join Prof. Rick Body and Dr Faheem Ahmad, for this upcoming online event.

High-sensitivity troponin T and troponin I are both widely used in the diagnosis of myocardial infarction. Together, we’ll cross the T and dot the I, reviewing the evidence, answering common questions, and sharing real-world experience to show why obtaining the right result at the right time matters most for patient care.

Overview
  • Evidence-based approaches to rapid chest pain assessment and the role of high-sensitivity troponin testing.
  • Practical strategies for integrating point-of-care testing and central laboratory services to support faster decision-making where it matters most.
  • Real-world experience of implementing point-of-care high-sensitivity troponin testing across multiple emergency departments, regardless of whether the laboratory uses Troponin T or Troponin I.

 

You say I, I say T, you say lab and I say POCT!
How to accelerate chest pain assessment –
Prof. Rick Body

Prof. Body examines questions on how to make rapid chest pain assessment really work:

  • How can we use point-of-care testing when there are patients waiting on corridors?
  • How do we make the link between central lab and point of care?
  • Should we always see the sickest patients first?
  • Despite all the research, why haven’t we conquered this problem yet?

Prof. Body will share practical, evidence-based insights into how clinicians can use troponin results with confidence to make timely decisions for patients presenting with chest pain.

Making the pathway work: bringing high-sensitivity troponin testing closer to the patient – Dr. Faheem Ahmad

Having led the rollout of point-of-care high-sensitivity troponin testing across six emergency departments, Dr. Ahmad draws on real-world experience from live, routine clinical practice where the laboratory uses high-sensitivity troponin T, while point-of-care testing uses high-sensitivity troponin I. Dr. Ahmad will share how these pathways have been successfully implemented and how they impact patient care. 

About the Presenters
200x200_Rick-Body-blue
 
Prof. Rick Body
 
Prof. Rick Body is Professor in Emergency Medicine, University of Manchester, UK. In his role and throughout his career, Prof. Body has spent time researching and improving the diagnosis of patients with suspected heart attacks.
 
200x200_F-Ahmad-blue
 
Dr. Faheem Ahmad
 
Dr. Faheem Ahmad is Consultant Cardiologist & Cardiology Innovation Lead, Queen Elizabeth University Hospital, Glasgow, Scotland and Cardiology Lead for the West of Scotland Innovation Hub.
 
REGISTER NOW
for this free, Abbott-sponsored webinar taking place Tuesday, 24 November 2026